Loss of 18q Alters TGFβ Signalling Affecting Anteroposterior Neuroectodermal Fate in Human Embryonic Stem Cells

Abstract

Chromosomal abnormalities acquired during cell culture can compromise the differentiation potential of human pluripotent stem cells (hPSCs). In this work, we identified a diminished differentiation capacity to retinal progenitor cells in human embryonic stem cells (hESCs) with complex karyotypes that had in common the loss of part of chromosome 18q. Time-course gene-expression analysis during spontaneous differentiation and single-cell RNA sequencing found that these variant cell lines poorly specified into anterior neuroectoderm, and, when progressing through differentiation, they yielded poorly pigmented cells, with proliferating and pluripotent cell populations. The variant cell lines showed dysregulation of TGFβ signalling during differentiation, and chemical modulation of the TGFβ pathways showed that the basis of the improper specification was due to imbalances in the anteroposterior neuroectodermal fate commitment.

References

[1] M. Zarbin, “Cell-Based Therapy for Degenerative Retinal Disease,” Trends in Molecular Medicine 22 (2016): 115–134.

[2] L. Da Cruz, F. K. Chen, A. Ahmado, J. Greenwood, and P. Coffey, “RPE Transplantation and Its Role in Retinal Disease,” Progress in Retinal and Eye Research 26 (2007): 598–635.

[3] M. S. Mehat, V. Sundaram, C. Ripamonti, et al., “Transplantation of Human Embryonic Stem Cell-Derived Retinal Pigment Epithelial Cells in Macular Degeneration,” Ophthalmology 125 (2018): 1765–1775.

[4] S. D. Schwartz, C. D. Regillo, B. L. Lam, et al., “Human Embryonic Stem Cell-Derived Retinal Pigment Epithelium in Patients With Age-Related Macular Degeneration and Stargardt's Macular Dystrophy: Follow-Up of Two Open-Label Phase 1/2 Studies,” Lancet 385 (2015): 509–516.

[5] L. Da Cruz, K. Fynes, O. Georgiadis, et al., “Phase 1 Clinical Study of an Embryonic Stem Cell-Derived Retinal Pigment Epithelium Patch in Age-Related Macular Degeneration,” Nature Biotechnology 36 (2018): 328–337.

[6] H. C. O'Neill, I. J. Limnios, and N. L. Barnett, “Advancing a Stem Cell Therapy for Age-Related Macular Degeneration,” Current Stem Cell Research & Therapy 15 (2019): 89–97.

[7] A. Vugler, A. J. Carr, J. Lawrence, et al., “Elucidating the Phenomenon of HESC-Derived RPE: Anatomy of Cell Genesis, Expansion and Retinal Transplantation,” Experimental Neurology 214 (2008): 347–361.

[8] P. W. Andrews, I. Barbaric, N. Benvenisty, et al., “The Consequences of Recurrent Genetic and Epigenetic Variants in Human Pluripotent Stem Cells,” Cell Stem Cell 29 (2022): 1624–1636.

[9] K. Amps, P. W. Andrews, G. Anyfantis, et al., “Screening Ethnically Diverse Human Embryonic Stem Cells Identifies a Chromosome 20 Minimal Amplicon Conferring Growth Advantage,” Nature Biotechnology 29 (2011): 1132–1144.

[10] F. T. Merkle, S. Ghosh, N. Kamitaki, et al., “Human Pluripotent Stem Cells Recurrently Acquire and Expand Dominant Negative P53 Mutations,” Nature 545 (2017): 229–233.

[11] K. Martins-Taylor, B. S. Nisler, S. M. Taapken, et al., “Recurrent Copy Number Variations in Human Induced Pluripotent Stem Cells,” Nature Biotechnology 29 (2011): 488–491.

[12] S. M. Taapken, B. S. Nisler, M. A. Newton, et al., “Karotypic Abnormalities in Human Induced Pluripotent Stem Cells and Embryonic Stem Cells,” Nature Biotechnology 29 (2011): 313–314.

[13] F. T. Merkle, S. Ghosh, G. Genovese, et al., “Whole-Genome Analysis of Human Embryonic Stem Cells Enables Rational Line Selection Based on Genetic Variation,” Cell Stem Cell 29 (2022): 472–486.e7.

[14] A. Keller and C. Spits, “The Impact of Acquired Genetic Abnormalities on the Clinical Translation of Human Pluripotent Stem Cells,” Cells 10 (2021): 10, https://doi.org/10.3390/CELLS10113246.

[15] A. Keller, D. Dziedzicka, F. Zambelli, et al., “Genetic and Epigenetic Factors Which Modulate Differentiation Propensity in Human Pluripotent Stem Cells,” Human Reproduction Update 24 (2018): 162–175.

[16] J. Halliwell, I. Barbaric, and P. W. Andrews, “Acquired Genetic Changes in Human Pluripotent Stem Cells: Origins and Consequences,” Nature Reviews. Molecular Cell Biology 21 (2020): 715–728.

[17] D. Al Delbany, M. S. Ghosh, N. Krivec, et al., “De Novo Cancer Mutations Frequently Associate With Recurrent Chromosomal Abnormalities During Long-Term Human Pluripotent Stem Cell Culture,” Cells 13 (2024): 13, https://doi.org/10.3390/cells13161395.

[18] Y. Lei, D. A. Delbany, N. Krivec, et al., “SALL3 Mediates the Loss of Neuroectodermal Differentiation Potential in Human Embryonic Stem Cells With Chromosome 18q Loss,” Stem Cell Reports 19 (2024): 562–578, https://doi.org/10.1016/J.STEMCR.2024.03.001.

[19] I. Mateizel, C. Spits, M. De Rycke, I. Liebaers, and K. Sermon, “Derivation, Culture, and Characterization of VUB hESC Lines,” In Vitro Cellular & Developmental Biology. Animal 46 (2010): 300–308.

[20] I. Mateizel, N. De Temmerman, U. Ullmann, et al., “Derivation of Human Embryonic Stem Cell Lines From Embryos Obtained After IVF and After PGD for Monogenic Disorders,” Human Reproduction 21 (2006): 503–511.

[21] C. Spits, I. Mateizel, M. Geens, et al., “Recurrent Chromosomal Abnormalities in Human Embryonic Stem Cells,” Nature Biotechnology 26 (2008): 1361–1363.

[22] B. Bayindir, L. Dehaspe, N. Brison, et al., “Noninvasive Prenatal Testing Using a Novel Analysis Pipeline to Screen for all Autosomal Fetal Aneuploidies Improves Pregnancy Management,” European Journal of Human Genetics 23 (2015): 1286–1293.

[23] A. Plaza Reyes, S. Petrus-Reurer, S. Padrell Sánchez, et al., “Identification of Cell Surface Markers and Establishment of Monolayer Differentiation to Retinal Pigment Epithelial Cells,” Nature Communications 11 (2020): 11, https://doi.org/10.1038/s41467-020-15326-5.

[24] A. Plaza, R. Sandra, P.-R. Sara, et al., Xeno-Free, Chemically Dened and Scalable Monolayer Differentiation Protocol for Retinal Pigment Epithelial Cells, 31 March 2020, PROTOCOL (Version 1) (2020), https://doi.org/10.21203/rs.3.pex-635/v1.

[25] A. Plaza Reyes, S. Petrus-Reurer, L. Antonsson, et al., “Xeno-Free and Defined Human Embryonic Stem Cell-Derived Retinal Pigment Epithelial Cells Functionally Integrate in a Large-Eyed Preclinical Model,” Stem Cell Reports 6 (2016): 9–17.

[26] I. J. Limnios, Y.-Q. Chau, S. J. Skabo, D. C. Surrao, and H. C. O'Neill, “Efficient Differentiation of Human Embryonic Stem Cells to Retinal Pigment Epithelium Under Defined Conditions,” Stem Cell Research & Therapy 12 (2021): 248.

[27] T. Kuroda, S. Yasuda, S. Tachi, et al., “SALL3 Expression Balance Underlies Lineage Biases in Human Induced Pluripotent Stem Cell Differentiation,” Nature Communications 10 (2019): 10, https://doi.org/10.1038/s41467-019-09511-4.

[28] E. E. Capowski, J. M. Simonett, E. M. Clark, et al., “Loss of MITF Expression During Human Embryonic Stem Cell Differentiation Disrupts Retinal Pigment Epithelium Development and Optic Vesicle Cell Proliferation,” Human Molecular Genetics 23 (2014): 6332–6344.

[29] P. Westenskow, S. Piccolo, and S. Fuhrmann, “β-Catenin Controls Differentiation of the Retinal Pigment Epithelium in the Mouse Optic Cup by Regulating Mitf and Otx2 Expression,” Development 136 (2009): 2505–2510.

[30] M. Parrish, T. Ott, C. Lance-Jones, G. Schuetz, A. Schwaeger-Nickolenko, and A. P. Monaghan, “Loss of the Sall3 Gene Leads to Palate Deficiency, Abnormalities in Cranial Nerves, and Perinatal Lethality,” Molecular and Cellular Biology 24 (2004): 7102–7112.

[31] M. Quevedo, L. Meert, M. R. Dekker, et al., “Mediator Complex Interaction Partners Organize the Transcriptional Network That Defines Neural Stem Cells,” Nature Communications 10 (2019): 10, https://doi.org/10.1038/s41467-019-10502-8.

[32] Y. Wang, X. Sun, B. Xiong, M. Duan, and Y. Sun, “Genetic and Environmental Factors co-Contributing to Behavioral Abnormalities in adnp/adnp2 Mutant Zebrafish,” International Journal of Molecular Sciences 25 (2024): 25, https://doi.org/10.3390/ijms25179469.

[33] M. Kushnir, E. Dresner, S. Mandel, and I. Gozes, “Silencing of the ADNP-Family Member, ADNP2, Results in Changes in Cellular Viability Under Oxidative Stress,” Journal of Neurochemistry 105 (2008): 537–545.

[34] X. Li, L. Zhu, A. Yang, et al., “Calcineurin-NFAT Signaling Critically Regulates Early Lineage Specification in Mouse Embryonic Stem Cells and Embryos,” Cell Stem Cell 8 (2011): 46–58.

[35] E. Lezmi, J. Jung, and N. Benvenisty, “High Prevalence of Acquired Cancer-Related Mutations in 146 Human Pluripotent Stem Cell Lines and Their Differentiated Derivatives,” Nature Biotechnology 42 (2024): 1667–1671, https://doi.org/10.1038/s41587-023-02090-2.

[36] H. Y. Jo, Y. Lee, H. Ahn, et al., “Functional In Vivo and In Vitro Effects of 20q11.21 Genetic Aberrations on hPSC Differentiation,” Scientific Reports 10 (2020): 1–15.

[37] C. Markouli, E. C. De Deckersberg, M. Regin, et al., “Gain of 20q11.21 in Human Pluripotent Stem Cells Impairs TGF-β-Dependent Neuroectodermal Commitment,” Stem Cell Reports 13 (2019): 163–176.

[38] L. Vitillo, F. Anjum, Z. Hewitt, et al., “The Isochromosome 20q Abnormality of Pluripotent Cells Interrupts Germ Layer Differentiation,” Stem Cell Reports 18 (2023): 782–797.

RIGHTS & PERMISSIONS

2025 The Author(s). Cell Proliferation published by Beijing Institute for Stem Cell and Regenerative Medicine and John Wiley & Sons Ltd.